Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China
AIDS Research and Human Retroviruses · 2023
DOI: 10.1089/aid.2022.0077 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2023. Verfasst von Xujian Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Collaborative Training Base of The First Hospital of Changsha, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Acquired Immunodeficiency Syndrome, Anti-HIV Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Collaborative Training Base of The First Hospital of Changsha, Hengyang Medical School, University of South China, Hengyang, China.
- The Institute of HIV/AIDS, The First Hospital of Changsha, Hunan, China.
ORCID-Profile: Xujian Cao
Zitieren
APA
Cao, X., Cao, J., Qi, H., Yu, W., Zeng, Z., Peng, Y., & Wang, M. (2023). Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2022.0077
Vancouver
Cao X, Cao J, Qi H, Yu W, Zeng Z, Peng Y, et al. Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China. AIDS Research and Human Retroviruses. 2023. doi:10.1089/aid.2022.0077
BibTeX
@article{Cao2023,
author = {Cao, Xujian and Cao, Jing and Qi, Hui and Yu, Weiwei and Zeng, Ziwei and Peng, Yongquan and Wang, Min},
title = {Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China},
journal = {AIDS Research and Human Retroviruses},
year = {2023},
doi = {10.1089/aid.2022.0077}
}
EUVIMED